These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9036566)
21. Nicotinamide in type 1 diabetes. Mechanism of action revisited. Kolb H; Burkart V Diabetes Care; 1999 Mar; 22 Suppl 2():B16-20. PubMed ID: 10097894 [TBL] [Abstract][Full Text] [Related]
22. Immune intervention in type I diabetes mellitus--current clinical and experimental approaches. Kolb H Exp Clin Endocrinol; 1994; 102(4):269-72. PubMed ID: 7813597 [TBL] [Abstract][Full Text] [Related]
23. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis. O'Brien BA; Harmon BV; Cameron DP; Allan DJ J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724 [TBL] [Abstract][Full Text] [Related]
24. Update on global intervention studies in type 1 diabetes. Chiang JL; Haller MJ; Schatz DA Endocrinol Metab Clin North Am; 2012 Dec; 41(4):695-712. PubMed ID: 23099265 [TBL] [Abstract][Full Text] [Related]
25. Effects of nicotinamide on prevention and treatment of streptozotocin-induced diabetes mellitus in rats. Hu Y; Wang Y; Wang L; Zhang H; Zhang H; Zhao B; Zhang A; Li Y Chin Med J (Engl); 1996 Nov; 109(11):819-22. PubMed ID: 9275363 [TBL] [Abstract][Full Text] [Related]
26. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans. Wang H; Li Y; Sun Q; Yang G Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099 [TBL] [Abstract][Full Text] [Related]
27. Prevention of insulin-dependent diabetes: where are we now? Pozzilli P Diabetes Metab Rev; 1996 Jul; 12(2):127-35. PubMed ID: 8877282 [No Abstract] [Full Text] [Related]
29. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic strategies for Type 1 and Type 2 diabetes mellitus. Giannoukakis N; Pietropaolo M; Trucco M Diabetes Nutr Metab; 2002 Jun; 15(3):173-203. PubMed ID: 12173733 [TBL] [Abstract][Full Text] [Related]
31. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration. Hutchings P; Cooke A J Autoimmun; 1998 Apr; 11(2):127-30. PubMed ID: 9650091 [TBL] [Abstract][Full Text] [Related]
32. Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes. Leiter LA Diabet Med; 2005 Aug; 22(8):963-72. PubMed ID: 16026359 [TBL] [Abstract][Full Text] [Related]
33. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides. Reddy S; Cheung CC; Chai RC; Rodrigues JA Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289 [TBL] [Abstract][Full Text] [Related]
35. [Analysis of the mechanism of the development of insulin-dependent diabetes mellitus and an attempt to prevent its onset by the functional T cell molecules]. Yokono K; Nagata M; Moriyama K; Tsukamoto K; Miki M; Yoneda R; Tominaga Y; Okamoto N; Yasuda N; Amano K; Kasuga M; Yagita H; Okumura Y Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):618-21. PubMed ID: 9081729 [No Abstract] [Full Text] [Related]
36. [Use of alpha-tocopherol acetate and nicotinamide at the onset of insulin dependent diabetes mellitus]. Dedov II; Gorelysheva VA; Romanovskaia GA; Filippov IK; Smirnova OM Klin Med (Mosk); 1995; 73(6):40-3. PubMed ID: 8691780 [No Abstract] [Full Text] [Related]